Gan & Lee developed the first Chinese domestic insulin analog and currently has a series of insulin products approved in China. Moreover, Gan & Lee formally concluded a strategic cooperation agreement with Sandoz, a subsidiary of Novartis, to expand developed markets. As a global company focusing on the health of human beings, Gan & Lee is committed to providing scientific solutions to patients across the globe to have a positive impact on patient lives.